Neuro-Oncology Reviews
Volume
25 Number 18
30 September 2023
Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 18, 30 Sptember
Park YW, Vollmuth P, Foltyn-Dumitru
M, Sahm F, Choi KS, Park JE, Ahn SS, Chang
JH, Kim SH.
The
2021 WHO Classification for Gliomas and Implications on
Imaging
Diagnosis: Part 3-Summary of Imaging Findings on Glioneuronal and
Neuronal
Tumors.
J Magn
Reson Imaging. 2023 Sep 16∟.
doi: 10.1002/jmri.29016∟.
PMID: 37715567∟.
Review. ˍ
Rabah N, Ait Mohand FE,
Kravchenko-Balasha N.
Understanding
Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug
Delivery Barriers.
Int
J Mol Sci. 2023 Sep 19;24(18):14256∟.
doi: 10.3390/ijms241814256∟.
PMID: 37762559∟.
Review. ˍ
van den Bent MJ, Geurts M, French
PJ, Smits M, Capper D, Bromberg JEC, Chang SM.
Primary
brain tumours in adults.
Lancet.
2023 Sep 19:S0140-6736(23)01054-1∟.
doi: 10.1016/S0140-6736(23)01054-1∟.
PMID: 37738997∟.
Review˰ ˍ
*
Harrison DJ, Wu E, Singh R, Ghaith
S, Suarez-Meade P, Brown NJ, Sherman WJ, Robinson
MT, Lin MP, Lawton MT, Quinones-Hinojosa A.
Primary
and Specialist Palliative
Care in Neurosurgery: A Narrative Review and Bibliometric Analysis
of Glioblastoma
and Stroke.
World
Neurosurg. 2023 Sep 20:S1878-8750(23)01316-5∟.
doi: 10.1016/j.wneu.2023.09.048∟.
PMID: 37739173∟.
Review, Bibliometric
analysis˰
ˍ
Li X, Wang J, Yuan G, Pan
Y.
Efficacy
of TTFields in high-grade gliomas: a protocol for systematic
review and meta-analysis.
BMJ
Open. 2023 Sep 20;13(9):e073753∟.
doi: 10.1136/bmjopen-2023-073753∟.
PMID: 37730390∟.
Review, Meta-analysis. ˍ
Winter SF, Vaios EJ, Shih HA,
Grassberger C, Parsons MW, Gardner MM, Ehret F, Kaul
D, Boehmerle W, Endres M, Dietrich J.
Mitigating
Radiotoxicity in the Central
Nervous System: Role of Proton Therapy.
Curr
Treat Options Oncol. 2023 Sep
20∟.
doi: 10.1007/s11864-023-01131-x∟.
PMID: 37728819∟.
Review˰ ˍ
Marwah R, Xing D, Squire T, Soon
YY, Gan HK, Ng SP.
Reirradiation
versus systemic
therapy versus combination therapy for recurrent high-grade
glioma: a systematic
review and meta-analysis of survival and toxicity.
J
Neurooncol. 2023 Sep 21∟.
doi: 10.1007/s11060-023-04441-0∟.
PMID: 37733174∟.
Review, Meta-analysis. ˍ
Ng S, Duffau H, Herbet G.
Perspectives
in human brain plasticity sparked by glioma invasion: from
intraoperative (re)mappings to neural reconfigurations.
Neural
Regen Res. 2023 Sep 22, 2024;19(5):947-948∟.
doi: 10.4103/1673-5374.382246∟.
PMID: 37862182∟.
Perspective. ˍ
Gan X, Liu Y, Wang X.
Targeting
androgen receptor in glioblastoma.
Crit
Rev Oncol Hematol. 2023 Sep
24;191:104142∟.
doi: 10.1016/j.critrevonc.2023.104142∟.
PMID: 37742885∟.
Review. ˍ
Bhatia S, Tonorezos ES, Landier
W.
Clinical
Care for People Who Survive
Childhood
Cancer: A Review.
JAMA.
2023 Sep 26;330(12):1175-1186∟.
doi: 10.1001/jama.2023.16875∟.
PMID: 37750876∟.
Review˰ ˍ
Pan I, Huang RY.
Artificial
intelligence in neuroimaging of brain tumors: reality or still
promise?
Curr
Opin Neurol. 2023 Sep 26;36(6):549-556∟.
doi: 10.1097/WCO.0000000000001213∟.
PMID: 37973024∟.
Review˰ ˍ
Rhee JY, Strander S, Podgurski A,
Chiu D, Brizzi K, Forst DA.
Palliative
Care in Neuro-oncology: an Update.
Curr
Neurol Neurosci Rep. 2023 Sep 26∟.
doi: 10.1007/s11910-023-01301-2∟.
PMID: 37751050∟.
Review˰ ˍ
Trivedi R, Bhat KP.
Liquid
biopsy: creating opportunities in brain space.
Br
J Cancer. 2023 Sep 26∟.
doi: 10.1038/s41416-023-02446-0∟.
PMID: 37752289∟.
Review˰ ˍ
Waite KA, Cioffi G, Malkin MG,
Barnholtz-Sloan JS.
Disease-Based
Prognostication:
Neuro-Oncology.
Semin
Neurol. 2023 Sep 26∟.
doi: 10.1055/s-0043-1775751∟.
PMID: 37751857∟.
Review˰ ˍ
Zoi V, Giannakopoulou M, Alexiou
GA, Bouziotis P, Thalasselis S, Tzakos AG, Fotopoulos A,
Papadopoulos AN, Kyritsis AP, Sioka C.
Nuclear
Medicine and Cancer Theragnostics: Basic Concepts.
Diagnostics
(Basel). 2023 Sep 26;13(19):3064∟.
doi: 10.3390/diagnostics13193064∟.
PMID: 37835806∟.
Review. ˍ
Jain P, Vashist S, Panjiyar
BK.
Navigating
the Immune Challenge in Glioblastoma: Exploring Immunotherapeutic
Avenues for Overcoming Immune Suppression.
Cureus.
2023 Sep 27;15(9):e46089∟.
doi: 10.7759/cureus.46089∟.
PMID: 37900496∟.
Review. ˍ
Muoio B, Espeli V, Treglia
G.
Neuro-Oncology
and Positron Emission Tomography: "Just Can't Get
Enough".
Cancers
(Basel). 2023 Sep 27;15(19):4739∟.
doi: 10.3390/cancers15194739∟.
PMID: 37835432∟.
Editorial. ˍ
Aydemir E, Arslan İİ,
Görkay AH.
The
Application of Electromagnetic Fields in
Cancer.
Adv
Exp Med Biol. 2023 Sep 28∟.
doi: 10.1007/5584_2023_788∟.
PMID: 37755661∟.
Review˰ ˍ
Bartusik-Aebisher D, Serafin I,
Dynarowicz K, Aebisher D.
Photodynamic
therapy and associated targeting methods for treatment of brain
cancer.
Front
Pharmacol. 2023 Sep 28;14:1250699∟.
doi: 10.3389/fphar.2023.1250699∟.
PMID: 37841921∟.
Review. ˍ
*
Pasqualetti F, Miniati M, Gonnelli
A, Gadducci G, Giannini N, Palagini L, Mancino M, Fuentes T, Paiar
F.
Cancer
Stem Cells and Glioblastoma: Time for Innovative Biomarkers of
Radio-Resistance?
Biology
(Basel). 2023 Sep 28;12(10):1295∟.
doi: 10.3390/biology12101295∟.
PMID: 37887005∟.
Review. ˍ
Pertichetti M, Corbo D, Belotti F,
Saviola F, Gasparotti R, Fontanella MM, Panciani
PP.
Neuropsychological
Evaluation and Functional Magnetic Resonance Imaging Tasks in the
Preoperative Assessment of Patients with Brain Tumors: A
Systematic Review.
Brain
Sci. 2023 Sep 28;13(10):1380∟.
doi: 10.3390/brainsci13101380∟.
PMID: 37891749∟.
Review. ˍ
Price M, Ryan K, Shoaf ML, Neff C, Iorgulescu JB, Landi DB, Cioffi
G, Waite KA, Kruchko C, Barnholtz-Sloan JS, Ostrom QT.
Childhood,
adolescent, and adult primary brain and central nervous system
tumor statistics for practicing healthcare providers in
neuro-oncology, CBTRUS 2015-2019.
Neurooncol
Pract. 2023 Sep 28;11(1):5-25. doi:
10.1093/nop/npad061. PMID:
38222052. Review. ˍ
Dal Bello S, Martinuzzi D, Tereshko
Y, Veritti D, Sarao V, Gigli GL, Lanzetta P, Valente M.
The
Present and Future of Optic Pathway Glioma Therapy.
Cells.
2023 Sep 29;12(19):2380∟.
doi: 10.3390/cells12192380∟.
PMID: 37830595∟.
Review. ˍ
De Vito A, Ben Zvi I, D'Arco F.
MR
Protocols for Paediatric Neurosurgical
Common
Conditions: An Update Guide for Neurosurgeons.
Adv
Tech Stand Neurosurg. 2023
Sep 29;48:57-72∟.
doi: 10.1007/978-3-031-36785-4_3∟.
PMID: 37770681∟.
Review˰ ˍ
Song KW, Wen PY.
Novel
trial designs in neuro-oncology.
Curr
Opin Neurol. 2023 Sep 29∟.
doi: 10.1097/WCO.0000000000001210∟.
PMID: 37865854∟.
Review˰ ˍ
Teske N, Tonn JC, Karschnia P.
How
to evaluate extent of resection in diffuse gliomas: from standards
to new methods.
Curr
Opin Neurol. 2023 Sep 29∟.
doi: 10.1097/WCO.0000000000001212∟.
PMID: 37865849∟.
Review˰ ˍ
Wen PY, van den Bent M, Youssef G,
Cloughesy TF, Ellingson BM, Weller M, Galanis E, Barboriak DP, de
Groot J, Gilbert MR, Huang R, Lassman AB, Mehta M, Molinaro AM,
Preusser M, Rahman R, Shankar LK, Stupp R, Villanueva-Meyer JE,
Wick W, Macdonald DR, Reardon DA, Vogelbaum MA, Chang SM.
RANO
2.0: Update to the Response Assessment in Neuro-Oncology Criteria
for High- and Low-Grade Gliomas in Adults.
J
Clin Oncol. 2023 Sep 29:JCO2301059∟.
doi: 10.1200/JCO.23.01059∟.
PMID: 37774317∟.
Guidelines˰ ˍ
Wen PY, van den Bent M, Vogelbaum
MA, Chang SM.
RANO
2.0: The revised Response Assessment in Neuro-Oncology (RANO)
Criteria for High- and Low-Grade Glial Tumors in Adults Designed
for the Future.
Neuro
Oncol. 2023 Sep 29:noad189∟.
doi: 10.1093/neuonc/noad189∟.
PMID: 37774741∟.
Editorial˰ ˍ
Refers
to: Wen PY, et al., RANO
2.0: Update to the Response Assessment in Neuro-Oncology Criteria
for High- and Low-Grade Gliomas in Adults.
J
Clin Oncol. 2023 Sep 29:JCO2301059∟.
doi: 10.1200/JCO.23.01059∟.
PMID: 37774317∟.
Guidelines˰ ˍ
Yakubov E, Ghoochani A, Savaskan
N.
Editorial:
Ferroptosis in malignant brain tumors.
Front
Oncol. 2023 Sep 29;13:1276971∟. doi:
10.3389/fonc.2023.1276971∟.
PMID: 37841440∟.
Editorial. ˍ
Alsulami TA, Hyare H, Thomas DL,
Golay X.
The
value of arterial spin labelling (ASL) perfusion MRI in the
assessment of post-treatment progression in adult glioma: A
systematic review and meta-analysis.
Neurooncol
Adv. 2023 Sep 30;5(1):vdad122∟.
doi: 10.1093/noajnl/vdad122∟.
PMID: 37841694∟.
Review, Meta-analysis. ˍ